Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 10, 2018 12:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Licenses CyPath® Lung to Precision Pathology Services

SAN ANTONIO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced a licensing agreement with Precision Pathology Services for the continued...
September 18, 2018 14:00 ET | Source: bioAffinity Technologies, Inc.

Mount Sinai Joins Test Validation Trial of bioAffinity’s CyPath® Lung

SAN ANTONIO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced that the Icahn School of Medicine at Mount Sinai (ISMMS) in New York, NY,...
July 19, 2017 15:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies Announces $4 Million Series A Funding

SAN ANTONIO, July 19, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held company advancing early-stage cancer diagnostics and precision therapeutics, announced today that it raised...
March 09, 2017 19:02 ET | Source: bioAffinity Technologies, Inc.

City of San Antonio Invests in bioAffinity Technologies

SAN ANTONIO, March 09, 2017 (GLOBE NEWSWIRE) -- The San Antonio City Council today authorized the San Antonio Economic Development Corporation (SAEDC) to invest in locally based bioAffinity...